Cargando…

TNK2 promoted esophageal cancer progression via activating egfr‐akt signaling

BACKGROUND: This study investigated the clinical implication of TNK2 expression in esophageal cancer patients’ cancer tissue samples. METHODS: The expression of TNK2 in esophageal cancer tissues and para‐carcinoma tissue was assessed with immunohistochemistry and Western blot analysis; besides, the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Anqing, Zhang, Rongxin, Yang, Zhiming, Tian, Rui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7958005/ https://www.ncbi.nlm.nih.gov/pubmed/33484472 http://dx.doi.org/10.1002/jcla.23700

Ejemplares similares

MOF Regulates TNK2 Transcription Expression to Promote Cell Proliferation in Thyroid Cancer
por: Li, Danyang, et al.
Publicado: (2020)

Recombinant human TNK tissue-type plasminogen activator (rhTNK-tPA) versus alteplase (rt-PA) as fibrinolytic therapy for acute ST-segment elevation myocardial infarction (China TNK STEMI): protocol for a randomised, controlled, non-inferiority trial
por: Wang, Hai-bo, et al.
Publicado: (2017)

ACK1/TNK2 Tyrosine Kinase: Molecular Signaling and Evolving Role in Cancers
por: Mahajan, Kiran, et al.
Publicado: (2014)

The noncatalytic regions of the tyrosine kinase Tnk1 are important for activity and substrate specificity
por: Ahmed, Sultan, et al.
Publicado: (2022)

NRP1 promotes prostate cancer progression via modulating EGFR-dependent AKT pathway activation
por: Zhang, Peng, et al.
Publicado: (2023)

RHBDD1 promotes proliferation, migration, invasion and EMT in renal cell carcinoma via the EGFR/AKT signaling pathway
por: Li, Mingyang, et al.
Publicado: (2021)

Ring finger protein 12 activates AKT signalling to promote the progression of liver cancer by interacting with EGFR
por: Yu, Chengpeng, et al.
Publicado: (2023)

ISGylation drives basal breast tumour progression by promoting EGFR recycling and Akt signalling
por: Bolado-Carrancio, Alfonso, et al.
Publicado: (2021)

Identification of an ACK1/TNK2-based prognostic signature for colon cancer to predict survival and inflammatory landscapes
por: Kong, Defeng, et al.
Publicado: (2022)

Epiplakin1 promotes the progression of esophageal squamous cell carcinoma by activating the PI3K‐AKT signaling pathway
por: Qiao, Zhongshi, et al.
Publicado: (2022)

JMJD8 Promotes Malignant Progression of Lung Cancer by Maintaining EGFR Stability and EGFR/PI3K/AKT Pathway Activation
por: Zhang, Bo, et al.
Publicado: (2021)

SAA1 knockdown promotes the apoptosis of glioblastoma cells via downregulation of AKT signaling
por: Zhang, Huikai, et al.
Publicado: (2021)

A novel antitumor dithiocarbamate compound inhibits the EGFR/AKT signaling pathway and induces apoptosis in esophageal cancer cells
por: Yang, Yun, et al.
Publicado: (2020)

Hypoxia-induced PLOD2 promotes clear cell renal cell carcinoma progression via modulating EGFR-dependent AKT pathway activation
por: Liu, Tao, et al.
Publicado: (2023)

Derlin-1 Promotes the Progression of Human Hepatocellular Carcinoma via the Activation of AKT Pathway
por: Fan, Jiye, et al.
Publicado: (2020)

Long Noncoding RNA LINC01485 Promotes Tumor Growth and Migration via Inhibiting EGFR Ubiquitination and Activating EGFR/Akt Signaling in Gastric Cancer
por: Zhou, Jianping, et al.
Publicado: (2020)

TRIM44 promotes human esophageal cancer progression via the AKT/mTOR pathway
por: Xiong, Dian, et al.
Publicado: (2018)

Blockade of ACK1/TNK2 To Squelch the Survival of Prostate Cancer Stem-like Cells
por: Mahajan, Nupam P., et al.
Publicado: (2018)

Entry by multiple picornaviruses is dependent on a pathway that includes TNK2, WASL, and NCK1
por: Jiang, Hongbing, et al.
Publicado: (2019)

CALM1 promotes progression and dampens chemosensitivity to EGFR inhibitor in esophageal squamous cell carcinoma
por: Liu, Tao, et al.
Publicado: (2021)

TIP-B1 promotes kidney clear cell carcinoma growth and metastasis via EGFR/AKT signaling
por: Yin, Lei, et al.
Publicado: (2019)

A Novel Putative Role of TNK1 in Atherosclerotic Inflammation Implicating the Tyk2/STAT1 Pathway
por: Bao, Mei-Hua, et al.
Publicado: (2020)

BRE Promotes Esophageal Squamous Cell Carcinoma Growth by Activating AKT Signaling
por: Jin, Fujun, et al.
Publicado: (2020)

NETO2 promotes esophageal cancer progression by inducing proliferation and metastasis via PI3K/AKT and ERK pathway
por: Xu, Jia-cheng, et al.
Publicado: (2021)

Rescue thrombolysis for medium vessel occlusion (RESCUE-TNK): Rationale and design of a phase 2 randomized trial
por: Hu, Hai-Zhou, et al.
Publicado: (2023)

Epigenetic silencing of IGFBPL1 promotes esophageal cancer growth by activating PI3K-AKT signaling
por: Liu, Yingge, et al.
Publicado: (2020)

ITGA2 Overexpression Promotes Esophageal Squamous Cell Carcinoma Aggression via FAK/AKT Signaling Pathway
por: Huang, Wei, et al.
Publicado: (2021)

Elevation of CD109 promotes metastasis and drug resistance in lung cancer via activation of EGFR‐AKT‐mTOR signaling
por: Lee, Kang‐Yun, et al.
Publicado: (2020)

ANGPTL4 Promotes the Proliferation of Papillary Thyroid Cancer via AKT Pathway
por: Yang, Longyan, et al.
Publicado: (2020)

Fusion crystallization reveals the behavior of both the 1TEL crystallization chaperone and the TNK1 UBA domain
por: Nawarathnage, Supeshala, et al.
Publicado: (2023)

CD73 promotes cervical cancer growth via EGFR/AKT1 pathway
por: Liu, Chong, et al.
Publicado: (2022)

Zyxin promotes hepatocellular carcinoma progression via the activation of AKT/mTOR signaling pathway
por: CAI, TIANYING, et al.
Publicado: (2023)

Cancer-associated fibroblasts-derived exosomal miR-3656 promotes the development and progression of esophageal squamous cell carcinoma via the ACAP2/PI3K-AKT signaling pathway
por: Jin, Yuan, et al.
Publicado: (2021)

Fibulin7 Mediated Pathological Cardiac Remodeling through EGFR Binding and EGFR‐Dependent FAK/AKT Signaling Activation
por: Zheng, Xuehui, et al.
Publicado: (2023)

Urokinase plasminogen activator secreted by cancer-associated fibroblasts induces tumor progression via PI3K/AKT and ERK signaling in esophageal squamous cell carcinoma
por: Tian, Baoqing, et al.
Publicado: (2017)

Downregulation of HADH promotes gastric cancer progression via Akt signaling pathway
por: Shen, Congcong, et al.
Publicado: (2017)

Midkine promotes glioblastoma progression via PI3K-Akt signaling
por: Hu, Beiquan, et al.
Publicado: (2021)

TRPC1 promotes the genesis and progression of colorectal cancer via activating CaM-mediated PI3K/AKT signaling axis
por: Sun, Yang, et al.
Publicado: (2021)

Terminal fucose mediates progression of human cholangiocarcinoma through EGF/EGFR activation and the Akt/Erk signaling pathway
por: Indramanee, Somsiri, et al.
Publicado: (2019)

MYH9 Promotes Growth and Metastasis via Activation of MAPK/AKT Signaling in Colorectal Cancer
por: Wang, Bin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_aq4of2fl6j9q7qu9oibdohva62